Cargando…

Asthma improvement in patients treated with dupilumab for severe atopic dermatitis

INTRODUCTION: Atopic dermatitis (AD) is considered a systemic type 2 immune driven disease, and it is associated to many atopic comorbidities including asthma. The aim of our study was to prospectively evaluate the respiratory outcomes in patients with persistent allergic asthma treated with dupilum...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dubini, Marco, Benzecry, Valentina, Rivolta, Federica, Sangalli, Andrea, Marzano, Angelo Valerio, Pravettoni, Valerio, Tavecchio, Simona, Ferrucci, Silvia Mariel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Allergy
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10518613/ https://www.ncbi.nlm.nih.gov/pubmed/37753208 http://dx.doi.org/10.3389/falgy.2023.1223657

Ejemplares similares

Transitory Dissemination of Molluscum Contagiosum in a Patient Treated with Dupilumab for Atopic Dermatitis
por: FERRUCCI, Silvia, et al.
Publicado: (2020)

Emerging Systemic Treatments for Atopic Dermatitis
por: Ferrucci, Silvia Mariel, et al.
Publicado: (2023)

Efficacy of Dupilumab on Different Phenotypes of Atopic Dermatitis: One-Year Experience of 221 Patients
por: Tavecchio, Simona, et al.
Publicado: (2020)

Skin barrier status during dupilumab treatment in patients with severe atopic dermatitis
por: Ferrucci, Silvia, et al.
Publicado: (2021)

Predictive Factors of Early Response to Dupilumab in Patients with Moderate-to-Severe Atopic Dermatitis
por: Ferrucci, Silvia, et al.
Publicado: (2023)

Clinical Response and Quality of Life in Patients with Severe Atopic Dermatitis Treated with Dupilumab: A Single-Center Real-Life Experience
por: Ferrucci, Silvia, et al.
Publicado: (2020)

Factors Associated with Affective Symptoms and Quality of Life in Patients with Atopic Dermatitis
por: FERRUCCI, Silvia Mariel, et al.
Publicado: (2021)

Dupilumab for atopic dermatitis
Publicado: (2019)

Successful adalimumab graded challenge after allergic delayed reaction to golimumab in a woman with rheumatoid arthritis
por: Rivolta, Federica, et al.
Publicado: (2023)

Is Dupilumab as Effective in Intrinsic Atopic Dermatitis as It Is in Extrinsic Atopic Dermatitis?
por: Gelato, Federica, et al.
Publicado: (2023)

Conjunctivitis in Dupilumab Clinical Trials for Adolescents with Atopic Dermatitis or Asthma
por: Bansal, Ashish, et al.
Publicado: (2021)

The positive effect of dupilumab on comorbid asthma in patients with atopic dermatitis
por: Spekhorst, Lotte S., et al.
Publicado: (2023)

Severe atopic dermatitis and dupilumab
por: Bernardo, Wanderley, et al.
Publicado: (2023)

Proteomics Profiling to Distinguish DOCK8 Deficiency From Atopic Dermatitis
por: Jacob, Minnie, et al.
Publicado: (2021)

Obesity and the microbiome in atopic dermatitis: Therapeutic implications for PPAR-γ agonists
por: McAleer, Jeremy P.
Publicado: (2023)

Survey of topical exposure concerns for patients and caregivers dealing with atopic dermatitis
por: Ratley, Grace, et al.
Publicado: (2023)

Conjunctivitis in patients with atopic dermatitis treated with dupilumab
por: Ferreira, Sandra, et al.
Publicado: (2020)

Efficacy of Dupilumab in severe Atopic Dermatitis (AD) using the AD Control Tool (ADCT) Score in the population of Qatar
por: Joy, Febu, et al.
Publicado: (2023)

A phase 2, open‐label study of single‐dose dupilumab in children aged 6 months to <6 years with severe uncontrolled atopic dermatitis: pharmacokinetics, safety and efficacy
por: Paller, A.S., et al.
Publicado: (2020)

Navigating patients with atopic dermatitis or chronic spontaneous urticaria during the COVID-19 pandemic
por: Haddad, Isabelle, et al.
Publicado: (2022)

Alopecia areata after dupilumab for atopic dermatitis
por: Mitchell, Krystal, et al.
Publicado: (2018)

Onychodystrophy associated with dupilumab therapy for atopic dermatitis
por: Zubek, Amanda E., et al.
Publicado: (2020)

Practical Management of Patients with Atopic Dermatitis on Dupilumab
por: Papp, Kim A., et al.
Publicado: (2021)

Efficacy of Dupilumab in Atopic Dermatitis: The Patient’s Perspective
por: de Bruin-Weller, Marjolein, et al.
Publicado: (2021)

The Posology of Dupilumab in Pediatric Patients With Atopic Dermatitis
por: Kamal, Mohamed A., et al.
Publicado: (2021)

Improvement of atopic dermatitis and alopecia universalis with dupilumab
por: Alotaibi, Lama, et al.
Publicado: (2021)

Dupilumab in the Treatment of Cheilitis in Atopic Dermatitis Patients
por: Shan, Jinpeng, et al.
Publicado: (2022)

Atopic Dermatitis with Multiple Comorbidities Treated with Dupilumab. A Case Report and Review of the Literature Regarding the Safety of Dupilumab
por: Mitroi, George G., et al.
Publicado: (2022)

Effect of immunosuppressive treatment on biomarkers in adult atopic dermatitis patients
por: Roekevisch, E., et al.
Publicado: (2020)

Poster 1023: Dupilumab suppresses Th2 inflammation in adult asthma and atopic dermatitis
por: Swanson, Brian, et al.
Publicado: (2014)

Both children and adult patients with difficult‐to‐treat atopic dermatitis have high prevalences of concomitant allergic contact dermatitis and are frequently polysensitized
por: Boonstra, M., et al.
Publicado: (2018)

Dupilumab: Direct Cost and Clinical Evaluation in Patients with Atopic Dermatitis
por: Ferrari, Marco, et al.
Publicado: (2023)

Validation of the Patient‐Oriented SCORing for Atopic Dermatitis tool for black skin
por: Faye, O., et al.
Publicado: (2019)

Rapid response to dupilumab treatment in children with moderate‐to‐severe atopic dermatitis: A case series
por: Votto, Martina, et al.
Publicado: (2022)

The evaluation of dupilumab treatment response in atopic dermatitis patients
por: Askin, Ozge, et al.
Publicado: (2020)

Dupilumab for the treatment of alopecia areata in children with atopic dermatitis
por: Cho, Sung Kyung, et al.
Publicado: (2021)

Successful fractionated undiluted doses of COVID‐19 vaccine in five cases of suspected allergic reactions to the first dose
por: Rivolta, Federica, et al.
Publicado: (2022)

Remission of a case of multiple Hymenoptera stings‐associated chronic urticaria during venom immunotherapy
por: Dubini, Marco, et al.
Publicado: (2021)

Remission of alopecia universalis in a patient with atopic dermatitis treated with dupilumab
por: Smogorzewski, Jan, et al.
Publicado: (2019)

Immune Thrombocytopenic Purpura in a Patient with Atopic Dermatitis Treated with Dupilumab
por: FREY, Surina, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_l14n03n9qu3cvarhur1fvq831p